Screening for Primary Hyperparathyroidism in Hypercalcemia
These educational modules aim to assist clinicians in identifying and screening for primary aldosteronism as part of this Precision Medicine quality improvement initiative by Baylor College of Medicine. Primary hyperparathyroidism has been selected for this initiative as recent evidence demonstrates it is the most common cause of outpatient hypercalcemia, underdiagnosis occurs across broad practice settings, and risk of fragility fractures, kidney stones, decline in kidney function, and neuropsychiatric symptoms.
Workflows in Addressing Under-diagnosis of Hyperparathyroidism
Dr. Zheng introduces the College's initiative in Precision Medicine and the second project, "Screening for Hyperparathyrdoism in Hypercalcemia." Dr. Zheng provides an overview of the evidence surrounding the previously unrecognized higher prevalence, potential benefits for participating clinicians, the clinical protocol, and the workflow for healthcare improvement with integrated CME and MOC credit.
0.25 hrs., Video, CME credit.
Update on Hyperparathyroidism
Dr. Zheng discusses the latest on primary hyperparathyroidism, the most common cause of hypercalcemia in the outpatient setting, for which many patients do not receive adequate workup. She also reviews the diagnostic criteria and surgical indications for this disorder.
0.25 hrs., Video, CME credit.
Evidence-based Diagnosis of Hyperparathyroidism in 2024
Dr. Zahid discusses the pathophysiology and epidemiology of hypercalcemia and hyperparathyroidism. She also highlights strategies to improve the clinical workflow for screening, evaluating, and treating patients who may have these diseases.
0.75 hrs., Video, CME credit.
Point-of-Care Activity
An activity in which a physician engages in self-directed, online learning on topics relevant to their clinical practice from a database whose content has been vetted by an accredited CME provider. Complementing the educational modules above are select point-of-care resources to facilitate clinician decision-making and screening and/or referral and/or further workup and management of patients with primary aldosteronism.